TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NKTR

Nektar Therapeutics

Healthcare · Biotechnology

43.60$ -7.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Nektar Therapeutics (NKTR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,095 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NKTR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
425 569 528 476 582 509 497 2,313 2,249 2,150 2,166 2,100 2,088 1,977 1,888 1,595 1,509 1,539 1,457 1,371 1,277 1,117 1,024 862 781 711 562 494 442 398 396 343 308 304 256 208 301 280 763 1,095
283 426 381 288 383 327 336 1,906 1,505 1,438 1,490 1,597 1,579 1,422 1,429 1,152 1,044 1,138 1,099 1,056 986 796 733 666 599 546 491 441 399 331 320 295 286 261 230 187 281 266 589 739
63 60 23 16 38 4.8 35 911 222 195 107 85 81 96 227 58 56 199 150 152 54 25 68 78 106 88 77 51 65 35 49 14 30 44 39 43 41 15 132 39
254 389 359 266 353 296 297 1,824 1,420 1,335 1,389 1,515 1,496 1,325 1,346 1,038 956 1,062 1,037 1,000 921 734 667 619 546 505 457 409 373 304 289 271 244 255 219 176 270 246 569 684
14 16 1.6 4.1 3.3 5.0 16 35 32 43 43 37 41 37 42 47 43 39 29 29 29 22 30 10 12 8.4 3.0 3.9 3.4 2.3 5.4 2.9 2.1 1.6 1.7 1.4 1.3 1.8 3.6 4.8
11 11 13 11 14 11 11 12 13 11 12 13 14 13 14 13 13 15 17 15 15 16 15 17 19 19 20 21 15 16 16 14 0.0 0.0 – – – – – –
66 66 67 65 62 47 46 45 45 49 58 65 65 65 62 61 60 60 59 181 59 178 61 40 103 86 27 23 – – – – – – – – – – – –
77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 0.0 0.0 0.0 0.0 – – – – – – – – – –
77 77 77 77 77 77 77 77 77 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
493 481 484 472 498 421 439 453 459 433 533 542 600 572 592 339 338 461 462 466 476 438 416 403 369 344 321 297 283 267 269 264 259 243 243 232 216 191 187 192
76 72 79 73 93 56 81 97 108 82 100 113 125 354 377 124 127 116 124 131 140 85 105 105 84 68 60 51 52 51 52 57 68 61 71 71 66 54 58 71
4.7 5.8 5.8 5.4 5.0 32 50 58 78 62 3.3 7.5 19 265 270 15 15 14 16 17 18 17 20 20 19 19 19 19 19 19 19 21 22 20 22 22 22 20 23 23
7.1 2.8 7.0 6.2 8.6 4.8 11 11 7.5 5.9 11 9.3 22 19 22 19 15 22 22 20 24 9.7 13 12 5.3 13 3.7 2.6 3.3 9.8 8.8 6.5 8.6 12 18 14 16 11 10 25
243 243 244 244 245 245 246 246 247 247 247 248 248 – – – – – – – – – – – – – – – – – – – – – – – – – – –
-68 88 45 3.4 84 88 58 1,860 1,790 1,718 1,634 1,557 1,489 1,405 1,296 1,256 1,171 1,077 995 905 802 680 608 459 412 367 241 197 159 131 127 80 49 61 14 -24 85 90 576 903
-1,979 -2,021 -2,085 -2,145 -2,084 -2,118 -2,201 -1,230 -1,326 -1,424 -1,543 -1,652 -1,751 -1,865 -2,003 -2,083 -2,192 -2,309 -2,432 -2,558 -2,687 -2,833 -2,923 -3,082 -3,142 -3,201 -3,338 -3,389 -3,435 -3,477 -3,514 -3,566 -3,603 -3,596 -3,647 -3,689 -3,724 -3,760 -3,805 -3,846
9.1 9.9 10 10 11 11 11 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 13 13 13 13 13 13 13 14 14 14 14 14 14 20 25 33

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?